Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ENROLLING BY INVITATION
NCT07443202
PHASE2

Study of Lotilaner Ophthalmic Gel in Patients With Ocular Rosacea (KORE)

Sponsor: Tarsus Pharmaceuticals, Inc.

View on ClinicalTrials.gov

Summary

To evaluate lotilaner treatment in patients with ocular rosacea.

Official title: A Randomized, Vehicle-Controlled, Multicenter, Double-Masked, Parallel, Phase 2 Study to Evaluate the Safety, Tolerability and Exploratory Efficacy of Lotilaner Ophthalmic Gel in Participants With Ocular Rosacea (KORE)

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

155

Start Date

2025-12-05

Completion Date

2027-12-31

Last Updated

2026-03-02

Healthy Volunteers

No

Conditions

Interventions

DRUG

lotilaner

lotilaner

DRUG

Vehicle

Vehicle of lotilaner

Locations (2)

Site

Houston, Texas, United States

Site

Lynchburg, Virginia, United States